Method for quantifying LBP in body fluids
AssigneeXoma Corporation
InventorsMark Leslie White, Stephen Fitzhugh Carroll, Jeremy Kam-kuen Ma
Life of this patent
Estimating the term…
Abstract
The present invention provides a method for quantifying the presence of extracellular LBP in body fluids including blood in a subject comprising conducting an LBP immunoassay on plasma obtained from said subject.
Claims5
A method for determining exposure to endotoxin of a human subject who has undergone surgery comprising the steps of determining the concentration of lipopolysaccharide binding protein (LBP) in a sample of body fluid from the subject and correlating the concentration of lipopolysaccharide binding protein with a standard indicative of the exposure to endotoxin, wherein the standard is an LBP concentration of the subject determined prior to undergoing surgery.
Dependencies are inferred from the claim text.